Henry Schein, Inc.
HSIC
Rangering i aksjer
#2167
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive... Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
Aksjekurs
$84.67
Sist synkronisert: 2026-10-20
Markedsverdi
$9.44B
Endring (1 dag)
0.84%
Endring (1 år)
31.83%
Land
US
Handel Henry Schein, Inc. (HSIC)
Kategori
Healthcare
P/E-forhold for Henry Schein, Inc. (HSIC)
P/E-forhold per October 2026 TTM: 24.73
Ifølge Henry Schein, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) 24.73. Ved slutten av 2023 hadde selskapet en P/E på 23.77.
P/E-forholdshistorikk for Henry Schein, Inc. fra 2000 til 2026
P/E-forhold ved slutten av hvert år
| År | P/E-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 24.73 | 8.03% |
| 2024 | 22.89 | -3.70% |
| 2023 | 23.77 | 17.68% |
| 2022 | 20.20 | 21.43% |
| 2021 | 16.64 | -28.39% |
| 2020 | 23.23 | 69.76% |
| 2019 | 13.69 | -21.39% |
| 2018 | 17.41 | -19.52% |
| 2017 | 21.63 | 14.87% |
| 2016 | 18.83 | -11.62% |
| 2015 | 21.31 | 9.37% |
| 2014 | 19.48 | 9.02% |
| 2013 | 17.87 | 26.38% |
| 2012 | 14.14 | 14.16% |
| 2011 | 12.39 | -8.13% |
| 2010 | 13.48 | 13.54% |
| 2009 | 11.88 | 16.81% |
| 2008 | 10.17 | -49.24% |
| 2007 | 20.03 | -2.92% |
| 2006 | 20.63 | 4.84% |
| 2005 | 19.68 | 8.99% |
| 2004 | 18.06 | 7.06% |
| 2003 | 16.86 | 29.44% |
| 2002 | 13.03 | -54.17% |
| 2001 | 28.43 | -28.91% |
| 2000 | 39.99 | 0.00% |
P/E-forhold for lignende selskaper eller konkurrenter
| Selskap | P/E-forhold | Forskjell i P/E-forhold | Land |
|---|---|---|---|
| 26.02 | 5.23% |
US
|
|
| - | - |
US
|
|
| 34.08 | 37.81% |
US
|
|
| - | - |
US
|
|
| 45.62 | 84.47% |
AU
|
Hvordan lese en P/E-ratio?
Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.
Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.
Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.